Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)

Market Cap	3.13B +0.2%
Revenue (ttm)	271.53M +14.5%
Net Income	6.83M -67.3%
EPS	0.01 -69.5%
Shares Out	405.07M
PE Ratio	457.86
Forward PE	n/a
Dividend	0.02 (0.22%)
Ex-Dividend Date	n/a

Volume	9,134,600
Average Volume	7,282,263
Open	7.82
Previous Close	8.05
Day's Range	7.71 - 8.00
52-Week Range	7.40 - 14.15
Beta	0.48
RSI	39.82
Earnings Date	Apr 27, 2026

About SHE:300942

Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatment column, certified reference, and quality control. It also provides specialized solutions, which include multi-mode precision detection, project pla...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 480
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300942

Financial Performance

In 2025, SHE:300942's revenue was 263.23 million, an increase of 17.38% compared to the previous year's 224.25 million. Earnings were 13.74 million, a decrease of -19.71%.